7310
J. O’Neill et al. / Tetrahedron Letters 49 (2008) 7307–7310
Table 5
the longevity of palladium catalysts and opens up possibilities
for other tandem oxidative palladium reactions.
The effect of various halo-arylboronic acids with 2-cyclohexen-1-one 9a,b
a
Typical procedure for the tandem reaction: To an oven dried
10 mL round-bottomed flask equipped with a stir bar was charged
0.10 mmol Pd(OAc)2, and 0.11 mmol 2,9-dimethyl phenanthroline
in 2.5 mL DMF. The reaction was stirred at room temperature for
30 minutes, at which time 2.0 mmol alkene was added, followed
by 1.0 mmol halo aryl boronic acid. The reaction flask was then
fitted with an oxygen balloon and stirred at room temperature
for 16 h, or at 50 °C for 6 h. Following confirmation of consumption
of starting material by TLC, the oxygen balloon was removed and
N2 was bubbled through the solution for at least 1 min. 1.2 mmol
aryl boronic acid and 2.0 mmol NaOH were then added to the
solution, and the solution was then stirred for up to 6 h under N2
at 90 °C. The reaction mixture was then dissolved in 50 mL ethyl
acetate and washed twice with 50 mL water, once with 50 mL
brine, and dried over anhydrous sodium sulfate and concentrated
in vacuo. The crude reaction mixture was then subjected to column
chromatography using a 10:1 hexane/ethyl acetate eluent system
on silica gel (230–400 mesh).
1) Pd(OAc) (10 mol %)
2
dmphen (11 mol %)
O , DMF, 16 h, RT
2
B(OH)
+
2
O
b
2) PhB(OH)
2
O
o
NaOH, N , 6 h, 90
2
C
Ph
X
Entry
1
Arylboronic acid
Product
Yieldc (%)
<5%
B(OH)
2
O
O
Cl
15
15
B(OH)
2
2
45
Br
I
B(OH)
2
O
3
4
52
32
Acknowledgment
24
25
We acknowledge generous financial support from the National
Institutes of General Medical Sciences of the National Institutes of
Health (RO1 GM 71495).
Cl
MeO
B(OH)
2
O
O
MeO
Supplementary data
OMe
OMe
B(OH)
Supplementary data associated with this article can be found, in
5
36
Cl
2
26
References and notes
a
All reactions were carried out with Arylboronic acid (1.0 mmol), 2-cyclohexen-
1-one (2.0 mmol), Pd(OAc)2 (10 mol%), and dmphen (11 mol%) in DMF (2.5 mL).
1. (a) Poetsch, E. Kontakte 1988, 2, 15; (b) Bemis, G. W.; Murcko, M. A. J. Med.
Chem. 1996, 39, 2887; (c) Pu, L. Chem. Rev. 1998, 98, 2405; (d) Hajduk, P. J.;
Bures, M.; Praestgaard, J.; Fesik, S. W. J. Med. Chem. 2000, 43, 3443; (e) Horton,
D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893; (f) Croom, K. F.;
Keating, G. M. Am. J. Cardiovasc. Drugs 2004, 4, 395.
b
Phenylboronic acid (1.2 mmol) and NaOH (2.0 mmol).
c
Isolated yields.
2. (a) Hernandez, S.; SanMartin, R.; Tellitu, I.; Dominguez, E. Org. Lett. 2003, 5,
1095; (b) Alberico, D.; Scott, M.; Lautens, M. Chem. Rev. 2007, 107, 174.
3. (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457; (b) Suzuki, A. J.
Organomet. Chem. 1999, 576, 147; (c) Kotha, S.; Lahiri, K.; Kashinath, D.
Tetrahedron 2002, 58, 9633; (d) Persichini, P. J. Curr. Org. Chem. 2003, 7, 1725;
(e) Bellina, F.; Carpita, A.; Rossi, R. Synthesis 2004, 2419.
4. (a) Negishi, E.; King, A. O.; Okukado, N. J. Org. Chem. 1977, 42, 1821; (b)
Rottaelander, M.; Palmer, N.; Knochel, P. Synlett 1996, 573; (c) Tilley, J. W.;
Clader, J. W.; Zawoiski, S.; Wirkus, M.; LeMahieu, R. A.; O’Donnell, M.; Crowley,
H.; Welton, A. F. J. Med. Chem. 1989, 32, 1814; (d) Hoye, T. R.; Chen, M. J. Org.
Chem. 1996, 61, 7940.
5. (a) Kosugi, M.; Hagiwara, I.; Migita, T. Chem. Lett. 1983, 839; (b) Stille, J. K.
Angew. Chem., Int. Ed. Engl. 1986, 98, 504; (c) Stanforth, S. P. Tetrahedron 1998,
54, 263.
6. (a) Kovacic, P.; Jones, M. B. Chem. Rev. 1987, 87, 357; (b) March, J. Advanced
Organic Chemistry, 4th ed.; Wiley: New York, 1992; p 539.
7. (a) Gomberg, M.; Bachmann, W. E. J. Am. Chem. Soc. 1924, 46, 2339; (b) March, J.
Advanced Organic Chemistry, 4th ed.; Wiley: New York, 1992; pp 715–171.
8. (a) Ullman, F.; Bielecki, J. Chem. Ber. 1901, 34, 2174; (b) Hassan, J.; Sevignon, M.;
Gozzi, C.; Shulz, E.; Lemaire, M. Chem. Rev. 2002, 102, 1359.
9. (a) Jung, Y. C.; Mishra, R. K.; Yoon, C. H.; Jung, K. W. Org. Lett. 2003, 5, 2231; (b)
Yoo, K. S.; Yoon, C. H.; Mishra, R. K.; Jung, Y. C.; Yi, S. W.; Jung, K. W. J. Am. Chem.
Soc. 2006, 128, 16384.
10. Moreno-Manas, M.; Perez, M.; Pleixats, R. J. Org. Chem. 1996, 61, 2346.
11. Conversion yields of the tandem reaction using various bases at 50 °C for 6 h
under N2 for the Suzuki coupling step; Na2CO3 (29%), K2CO3 (24%), K3PO4 (37%),
and triethyl-amine (25%).
efficiently to biaryl product 15 in 67% yield (Table 4, entry 1), while
chloro- and bromo-phenylboronic acid afforded the desired prod-
uct in 15% and 45% yields, respectively (entries 1 and 2). This is be-
cause aryl bromide and iodide easily react with phenylboronic acid
but chloride does not participate in coupling readily. Furthermore,
3-iodophenyl-boronic acid reacted with 2-cyclohexen-1-one, and
then phenylboronic acid to give a 52% yield of 24 (entry 3). In
the case of di-substituted arylboronic acids including 3-chloro-
4-methoxyphenyl boronic acid and 5-chloro-2-methoxyphenyl-
boronic acid, tandem reactions with 2-cyclohexen-1-one and
phenylboronic acid afforded regioselective desired products 25
and 26 in 32% and 36% yields, respectively (entries 4 and 5).
In conclusion, a tandem oxidative boron-Heck/Suzuki coupling
reaction was developed for the preparation of biaryls in good to
moderate yields. The reaction can be performed with variation at
all three coupling partners. In addition, the biaryls formed in this
study were obtained without the use of long laborious purification
or the further addition of more palladium catalyst between
coupling reactions. Furthermore, the use of different atmospheric
conditions, and consequently, different mechanisms, allows for